inne is a Berlin-based biotech startup founded in 2016. The company's slogan "Measure your daily progesterone levels with the inne minilab to track your fertility and decode your cycle" encapsulates its core offering. inne aims to revolutionize women's health by providing a more accurate and convenient way to track fertility. With a focus on leveraging biochemistry and technology, inne offers a 30-second at-home saliva test that predicts and confirms ovulation using actual hormone levels. This data is then interpreted through an app to help users understand the implications for their fertility. The company's last major milestone was a €9.34M Series A investment led by Borski Fund, DSM Venturing, Calm/Storm, Rolf Schromgens, Taavet Hinrikus, Fiona Pathiraja on 25 May 2022. With its innovative approach and strong investor backing, inne is poised to make significant strides in the Biotechnology, Health Care, Health and Wellness industries.
No recent news or press coverage available for inne.